TFAP2A has been found to be associated with a variety of tumors and is highly expressed in a variety of tumor cells including glioma, gastric cancer, bile duct cancer, breast cancer, and colorectal cancer, regulating tumor proliferation and apoptosis (41–44). Here, TFAP2A is linked to breast carcinoma.